4//SEC Filing
Shea Jacqueline Elizabeth 4
Accession 0001055726-24-000022
CIK 0001055726other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 4:57 PM ET
Size
9.3 KB
Accession
0001055726-24-000022
Insider Transaction Report
Form 4
Shea Jacqueline Elizabeth
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2024-05-10−5,500→ 5,500 total→ Common Stock (5,500 underlying) - Exercise/Conversion
Common Stock
2024-05-10+5,500→ 26,012 total - Tax Payment
Common Stock
2024-05-10$10.65/sh−2,392$25,475→ 23,620 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 16,500 restricted stock units is as follows: 5,500 shares vested on May 10, 2023; 5,500 shares vested on May 10, 2024; and 5,500 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
- [F2]Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024.
- [F3]The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeother
Related Parties
1- filerCIK 0001771498
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 4:57 PM ET
- Size
- 9.3 KB